相关实验视频
Updated: Sep 19, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
在晚期卵巢癌的cytoreductive手术后REACT肠道恢复
Virginia Vargiu1, Andrea Rosati1, Francesco Santullo2
1Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
低前切除综合征 (LARS) 和便秘在卵巢癌手术后很常见. 缩短肠切除是这些肠道功能障碍的关键风险因素,影响患者的生活质量.
科学领域:
- 妇科瘤学 妇科瘤学
- 手术瘤学手术瘤学
- 患者研究成果研究结果
背景情况:
- 卵巢癌的细胞还原性手术可以导致显著的术后发病率.
- 了解功能缺陷的患病率和预测因素对于优化患者护理至关重要.
- 低前切除综合征 (LARS) 和其他肠道功能障碍是已知的盆腔手术并发症.
研究的目的:
- 为了确定LARS在卵巢癌患者的发生率,在细胞减小手术后.
- 识别与肠道,泌尿和性功能障碍相关的危险因素.
- 评估转向口腔切除术对这些患者生活质量的影响.
主要方法:
- 使用验证的问卷来评估肠道 (LARS分数,KESS),尿道 (BFLUTS) 和性 (FSFI) 功能障碍.
- 在使用STOMA-QoL尺度评估的患者中,评估了生活质量.
- 使用后勤回归分析来确定观察到的功能障碍的预测因素.
主要成果:
- 总共有8.8%的患者报告了LARS,慢性便秘更为普遍 (48.4%).
- 下肠切除高度 (≤5厘米) 是LARS和便秘的最强预测因素.
- 尿路功能障碍影响了35.2%,性功能障碍68%,而骨患者报告生活质量低于最佳水平,尽管随着时间的推移情况有所改善.
结论:
- 手术后的肠功能障碍,特别是慢性便秘,对卵巢癌患者在细胞减小手术后面临重大挑战.
- 切除高度,淋巴切除术和疾病复发是影响肠道功能障碍的关键因素.
- 尿路和性功能障碍的高发病率需要对幸存者护理采取全面的,多学科的方法.
更多相关视频
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
11:29Surgical Techniques to Optimize Ovarian Reserve during Laparoscopic Cystectomy for Ovarian Endometrioma
Published on: January 22, 2022
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...